Search ClinicalTrials.gov with query= (company, drug, or intervention name).
https://api.edifiedlab.com/v1/market/clinical-trialsOverview
Search ClinicalTrials.gov with query= (company, drug, or intervention name).
Protocol
x402
Price
$0.01
Payment Asset
USDC
Payment Network
eip155:8453
Category
tools/search
Provider
Clinical Trials
Source
bazaar
Indexed
2026-09-17 15:14:19
Health
Status
healthy
Latency (p50)
476ms
Uptime (30d)
100.0%
Reliability Score
95/100
Last Checked
2026-10-28 06:43:26
Last Healthy
2026-10-28 06:43:26
Consecutive Failures
0
x402 Payment Validation
Payment Requirements
Valid
Asset Verified
Known USDC
Facilitator
—
Input Schema
{
"method": "GET",
"queryParams": {
"max_results": 10,
"query": "Nivolumab"
},
"type": "http"
}
Output Schema
{
"example": {
"action": "search",
"disclaimer": "Clinical-trial registry lookup only; not medical advice or proof of treatment efficacy.",
"payload": "clinical_trials",
"phase": null,
"query": "Nivolumab",
"results": [
{
"conditions": [
"Advanced Biliary Tract Cancer",
"Neuroendocrine Tumors",
"Female Reproductive System Neoplasm",
"MSI-H Solid Malignant Tumor"
],
"enrollment": 240,
"nct_id": "NCT04969887",
"phase": "PHASE2",
"phases": [
"PHASE2"
],
"primary_completion": "2025-03-01",
"sponsor": "Olivia Newton-John Cancer Research Institute",
"status": "ACTIVE_NOT_RECRUITING",
"title": "Combination Immunotherapy in Rare Cancers Under InvesTigation",
"url": "https://clinicaltrials.gov/study/NCT04969887"
}
],
"summary": "Clinical trials for 'Nivolumab' (1247 total, showing 1):\n\n NCT04969887 Phase PHASE2 [ACTIVE_NOT_RECRUITING]\n Title: Combination Immunotherapy in Rare Cancers Under InvesTigation\n Condition: Advanced Biliary Tract Cancer, Neuroendocrine Tumors, Female Reproductive System Neoplasm\n Sponsor: Olivia Newton-John Cancer Research Institute Enrollment: 240 Primary completion: 2025-03-01\n https://clinicaltrials.gov/study/NCT04969887",
"total_count": 1247
},
"type": "json"
}